H1N1 flu :: Pandemic swine flu – H1N1 Influenza

Novel H1N1 (referred to as “swine flu” early on) is a new influenza virus causing illness in people. This new virus was first detected in people in the United States in April 2009. Other countries, including Mexico and Canada, have reported people sick with this new virus. This virus is spreading from person-to-person, probably in much the same way that regular seasonal influenza viruses spread.

Eye :: $2 million of potentially harmful cosmetic eye product seized in US

Harmful cosmetic eye products may increase the risk of optic nerve damage, macular edema, uveitis leading to decreased vision and blindness. At the request of the U.S. Food and Drug Administration, U.S. Marshals seized 12,682 applicator tubes of Age Intervention Eyelash, a product that may, in some users, lead to decreased vision. Authorities said the sales value of the seized tubes is approximately $2 million.

Healthcare :: A dose of God may help medicine

For some families, the cancer diagnosis of a child strengthens existing religious ties or prompts new ones. Now, a new study by researchers at Brandeis University and the University at Buffalo – SUNY in Pediatric Hematology and Oncology reports that while most pediatric oncologists say they are spiritual, and many are open to connecting with the families of very sick children through religion or spirituality, they typically lack the formal healthcare training that could help them build such bridges.

Hearing Loss :: Genes influence age-related hearing loss

A new Brandeis University study of twins shows that genes play a significant role in the level of hearing loss that often appears in late middle age. The research, in the Journal of Gerontology: Medical Sciences, examined genetic and environmental factors affecting hearing loss in the frequency range of speech recognition.

Ovarian Cancer :: New Therapy for Patients with Platinum-Resistant Ovarian Cancer

Mayo Clinic reported promising interim results from a Phase II trial of a new combination therapy for patients with recurrent ovarian cancer that is resistant to platinum therapy. Thirty-three percent of study participants achieved either complete or partial tumor regression from the therapy, which combines flavopiridol and cisplatin.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack